{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:52:27Z","timestamp":1793307147476,"version":"4.5.0"},"reference-count":298,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Open Respiratory Archives"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.opresp.2024.100392","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T12:54:24Z","timestamp":1732366464000},"page":"100392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Respiratory Pathology and Cardiovascular Diseases: A Scoping Review"],"prefix":"10.1016","volume":"7","author":[{"given":"Francisco","family":"Campos-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eusebi","family":"Chiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"de la Rosa-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6388-8209","authenticated-orcid":false,"given":"Borja G.","family":"Cos\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas R.","family":"Hern\u00e1dez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Gregorio","family":"Soto-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Manuel","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco-Javier","family":"Gonzalez-Barcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.opresp.2024.100392_bib1000","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.opresp.2022.100230","article-title":"Questions and answers in tobacco smoking","volume":"5","author":"\u00c1lvarez Mav\u00e1rez","year":"2023","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.opresp.2024.100392_bib1005","doi-asserted-by":"crossref","first-page":"100229","DOI":"10.1016\/j.opresp.2022.100229","article-title":"Impact of air pollution on asthma: a scoping review","volume":"5","author":"Bronte-Moreno","year":"2023","journal-title":"Open Respir Arch"},{"issue":"Suppl. 1","key":"10.1016\/j.opresp.2024.100392_bib1010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0300-2896(11)70007-2","article-title":"The air belongs to us: the importance of maintaining air quality","volume":"47","author":"Rodr\u00edguez Portal","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib1015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.arbres.2012.04.005","article-title":"Indoor air contaminants and their impact on respiratory pathologies","volume":"49","author":"Carazo Fern\u00e1ndez","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib1020","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.jacc.2020.12.003","article-title":"Taking a stand against air pollution-the impact on cardiovascular disease: a joint opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology","volume":"77","author":"Brauer","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1025","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1080\/09603123.2023.2225426","article-title":"Lifetime losses due to cardiovascular and respiratory diseases attributable to air pollution in polluted and unpolluted areas","volume":"34","author":"Ji\u0159\u00edk","year":"2024","journal-title":"Int J Environ Health Res"},{"key":"10.1016\/j.opresp.2024.100392_bib1030","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.opresp.2022.100202","article-title":"Use of systemic glucocorticoids for the treatment of severe asthma: Spanish Multidisciplinary Consensus","volume":"4","author":"Dom\u00ednguez-Ortega","year":"2022","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.opresp.2024.100392_bib1035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/COPD.S358927","article-title":"Association between inhaled \u03b22-agonists initiation and risk of major adverse cardiovascular events: a population-based nested case\u2013control study","volume":"17","author":"Amegadzie","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.opresp.2024.100392_bib1040","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2018.11.063","article-title":"Association of cardiovascular disease with respiratory disease","volume":"73","author":"Carter","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1045","doi-asserted-by":"crossref","first-page":"100249","DOI":"10.1016\/j.opresp.2023.100249","article-title":"The relevance of comorbidities in the persistence of exacerbations in patients with chronic obstructive pulmonary disease","volume":"5","author":"Figueira-Gon\u00e7alves","year":"2023","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.opresp.2024.100392_bib1050","article-title":"Unmet needs in severe allergic asthma","volume":"5","author":"Delgado","year":"2023","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.opresp.2024.100392_bib1055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2021.05.048","article-title":"Sleep disordered breathing and cardiovascular disease: JACC state-of-the-art review","volume":"78","author":"Cowie","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"Corrales-Medina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.opresp.2024.100392_bib1070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ejim.2014.10.023","article-title":"Adult asthmatics increase the risk of acute coronary syndrome: a nationwide population-based cohort study","volume":"25","author":"Chung","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.arbres.2023.01.005","article-title":"Relationship between the summation of GesEPOC high-risk factors and the presence of cardiovascular disease","volume":"59","author":"Figueira-Gon\u00e7alves","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib1080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arbres.2022.11.001","article-title":"Cardiovascular protection in sleep apnea: is it a question of CPAP adherence?","volume":"59","author":"Bailly","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib1085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.arbres.2021.01.026","article-title":"Prevalence of obstructive sleep apnoea and its association with atherosclerotic plaques in a cohort of subjects with mild\u2013moderate cardiovascular risk","volume":"58","author":"Sapi\u00f1a-Beltr\u00e1n","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib1090","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacc.2016.11.069","article-title":"Sleep apnea: types, mechanisms, and clinical cardiovascular consequences","volume":"69","author":"Javaheri","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1105","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.opresp.2024.100392_bib1110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0002-8703(84)90628-8","article-title":"Prevalence of sleep apnea syndrome among patients with essential hypertension","volume":"108","author":"Lavie","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib1115","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.283.14.1829","article-title":"Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study","volume":"283","author":"Nieto","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.opresp.2024.100392_bib1120","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","article-title":"High prevalence of unrecognized sleep apnoea in drug-resistant hypertension","volume":"19","author":"Logan","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.opresp.2024.100392_bib1125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","article-title":"Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension","volume":"58","author":"Pedrosa","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.opresp.2024.100392_bib1130","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/sleep\/31.6.795","article-title":"Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study","volume":"31","author":"Hla","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.opresp.2024.100392_bib1140","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.opresp.2024.100392_bib1145","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.opresp.2024.100392_bib1150","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1212\/WNL.0000000000006904","article-title":"Prevalence of sleep-disordered breathing after stroke and TIA: a meta-analysis","volume":"92","author":"Seiler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.opresp.2024.100392_bib1155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/STROKEAHA.118.023807","article-title":"Sleep-disordered breathing is associated with recurrent ischemic stroke","volume":"50","author":"Brown","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.opresp.2024.100392_bib1160","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCOUTCOMES.111.964783","article-title":"Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis","volume":"5","author":"Loke","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.opresp.2024.100392_bib1165","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Meschia","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.opresp.2024.100392_bib1170","first-page":"75","article-title":"Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome","volume":"4","author":"Nakashima","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.opresp.2024.100392_bib1175","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1378\/chest.07-2544","article-title":"Independent association between obstructive sleep apnea and subclinical coronary artery disease","volume":"133","author":"Sorajja","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5665\/sleep.4654","article-title":"Coronary heart disease incidence in sleep disordered breathing: the Wisconsin sleep cohort study","volume":"38","author":"Hla","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/j.opresp.2024.100392_bib1185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11325-009-0298-7","article-title":"Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death","volume":"14","author":"Shah","year":"2010","journal-title":"Sleep Breath"},{"key":"10.1016\/j.opresp.2024.100392_bib1190","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1161\/CIRCULATIONAHA.115.019392","article-title":"Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention","volume":"133","author":"Lee","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.opresp.2024.100392_bib1195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2213-2600(12)70051-6","article-title":"Obstructive sleep apnoea and cardiovascular disease","volume":"1","author":"S\u00e1nchez-de-la-Torre","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1200","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/ehn214","article-title":"Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function","volume":"29","author":"Stevenson","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib1205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2006.08.060","article-title":"Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation","volume":"49","author":"Gami","year":"2007","journal-title":"JJ Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004500","article-title":"Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women","volume":"6","author":"Tung","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.opresp.2024.100392_bib1215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2011.02.343","article-title":"Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation","volume":"108","author":"Ng","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1220","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa041832","article-title":"Day-night pattern of sudden death in obstructive sleep apnea","volume":"352","author":"Gami","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejheart.2006.08.003","article-title":"Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients","volume":"9","author":"Oldenburg","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.opresp.2024.100392_bib1230","first-page":"1071","article-title":"Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort","volume":"31","author":"Young","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.opresp.2024.100392_bib1235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000132","article-title":"Sleep-disordered breathing and mortality: a prospective cohort study","volume":"6","author":"Punjabi","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5664\/jcsm.3600","article-title":"Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort","volume":"10","author":"Marshall","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1245","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(05)71141-7","article-title":"Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study","volume":"365","author":"Marin","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.opresp.2024.100392_bib1250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.7326\/0003-4819-156-2-201201170-00006","article-title":"Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study","volume":"156","author":"Campos-Rodriguez","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1255","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1164\/rccm.201203-0448OC","article-title":"Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study","volume":"186","author":"Mart\u00ednez-Garc\u00eda","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1260","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.3390\/ijms20225563","article-title":"Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases","volume":"20","author":"Zanatta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.opresp.2024.100392_bib1265","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.arbres.2012.11.005","article-title":"Pulmonary manifestations of collagen diseases","volume":"49","author":"G\u00f3mez Carrera","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib1280","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/rheumatology\/kez456","article-title":"Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study","volume":"59","author":"Lai","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.opresp.2024.100392_bib1285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/157340308784245775","article-title":"Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors","volume":"4","author":"Zeller","year":"2008","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.opresp.2024.100392_bib1290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2016.08.298","article-title":"Cardiac involvement in patients with rheumatic disorders: data of the RHEU-M(A)R study","volume":"224","author":"Greulich","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1295","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1300","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2018.10.021","article-title":"Cardiac sarcoidosis","volume":"123","author":"Tan","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1305","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1681\/ASN.V10112446","article-title":"Anti-glomerular basement membrane disease","volume":"10","author":"Kluth","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.opresp.2024.100392_bib1310","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2012.375","article-title":"Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease","volume":"83","author":"Tang","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.opresp.2024.100392_bib1315","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(01)06077-9","article-title":"Goodpasture's disease","volume":"358","author":"Salama","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.opresp.2024.100392_bib1320","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V641178","article-title":"Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome","volume":"6","author":"Kalluri","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.opresp.2024.100392_bib1325","first-page":"10E","article-title":"Enfermedad cardiovascular y funci\u00f3n renal. Mecanismos patog\u00e9nicos","volume":"8","author":"Gonz\u00e1lez","year":"2008","journal-title":"Rev Esp Cardiol Supl"},{"key":"10.1016\/j.opresp.2024.100392_bib1330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2500\/aap.2013.34.3628","article-title":"Primary eosinophilic lung diseases","volume":"34","author":"Rose","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.opresp.2024.100392_bib1335","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.hlc.2008.06.003","article-title":"Eosinophilia and coronary artery vasospasm","volume":"17","author":"Wong","year":"2008","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.opresp.2024.100392_bib1340","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232472","article-title":"Kounis syndrome uncovers severe coronary disease: an unusual case of acute coronary syndrome secondary to allergic coronary vasospasm","volume":"12","author":"Conti","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1345","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jaip.2018.07.001","article-title":"Eosinophilic granulomatosis with polyangiitis: clinical pathology conference and review","volume":"6","author":"Wu","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.opresp.2024.100392_bib1350","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anai.2018.05.014","article-title":"Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia","volume":"121","author":"Zimmermann","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.opresp.2024.100392_bib1355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11899-018-0448-8","article-title":"Diagnosis and novel approaches to the treatment of hypereosinophilic syndromes","volume":"13","author":"Dispenza","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1360","article-title":"Is there a correlation between new scoring systems and systemic inflammation in stable bronchiectasis?","volume":"017","author":"Coban","year":"2017","journal-title":"Can Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib1365","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.opresp.2024.100392_bib1370","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.atherosclerosis.2006.09.027","article-title":"Acceleration of atherosclerosis during the course of rheumatoid arthritis","volume":"195","author":"Del Rincon","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.opresp.2024.100392_bib1375","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1380","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1479972312459973","article-title":"Systemic comorbidities in bronchiectasis","volume":"9","author":"Gale","year":"2012","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.opresp.2024.100392_bib1385","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.07-1639","article-title":"Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis","volume":"133","author":"Alzeer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1390","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/thoraxjnl-2015-208188","article-title":"Bronchiectasis and the risk of cardiovascular disease: a population-based study","volume":"72","author":"Navaratnam","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.opresp.2024.100392_bib1395","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.rmed.2007.02.002","article-title":"Analysis of the factors related to mortality in patients with bronchiectasis","volume":"101","author":"Onen","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1400","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2016.09.022","article-title":"Bronchiectasis severity is an independent risk factor for vascular disease in a bronchiectasis cohort","volume":"151","author":"Evans","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1405","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01127-2017","article-title":"Correlates and assessment of excess cardiovascular risk in bronchiectasis","volume":"50","author":"Saleh","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib1410","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1415","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12890-020-1137-7","article-title":"Clinical impact of cardiovascular disease on patients with bronchiectasis","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1420","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12931-017-0659-x","article-title":"Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study","volume":"18","author":"Men\u00e9ndez","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.opresp.2024.100392_bib1425","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2214\/AJR.10.5221","article-title":"Pulmonary hypertension in patients with bronchiectasis: prognostic significance of CT signs","volume":"196","author":"Devaraj","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.opresp.2024.100392_bib1430","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11684-016-0461-z","article-title":"Clinical characteristics of pulmonary hypertension in bronchiectasis","volume":"10","author":"Wang","year":"2016","journal-title":"Front Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1435","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.17219\/acem\/144200","article-title":"The influence of comorbidities on mortality in bronchiectasis: a prospective, observational study","volume":"30","author":"Nowi\u0144ski","year":"2021","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1440","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1445","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.202002-0434LE","article-title":"Serum desmosine is associated with long-term all-cause and cardiovascular mortality in bronchiectasis","volume":"202","author":"Huang","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1450","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/RTI.0000000000000553","article-title":"Coronary artery calcification on thoracic computed tomography is an independent predictor of mortality in patients with bronchiectasis","volume":"36","author":"Williams","year":"2021","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.opresp.2024.100392_bib1455","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1157\/13114651","article-title":"The association between bronchiectasis, systemic inflammation, and tumor necrosis factor alpha","volume":"44","author":"Mart\u00ednez-Garc\u00eda","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib1460","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1465","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1399-3003.2000.16d21.x","article-title":"Up-regulation of circulating adhesion molecules in bronchiectasis","volume":"16","author":"Zheng","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib1470","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1183\/09031936.00122508","article-title":"Assessing response to treatment of exacerbations of bronchiectasis in adults","volume":"33","author":"Murray","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib1475","series-title":"Cardiovascular complications of respiratory disorders (ERS monograph)","first-page":"96","article-title":"Cardiovascular implications in bronchiectasis","author":"Guan","year":"2020"},{"key":"10.1016\/j.opresp.2024.100392_bib1480","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMra1805377","article-title":"Treating hypertension in chronic obstructive pulmonary disease","volume":"382","author":"Finks","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1485","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12931-021-01661-8","article-title":"Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison","volume":"22","author":"Gulea","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.opresp.2024.100392_bib1490","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-201001","article-title":"Massive haemoptysis following dabigatran administration in a patient with bronchiectasis","volume":"2014","author":"Hayama","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1495","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211053316","article-title":"Risk of severe bleeding with extended rivaroxaban to prevent venous thromboembolism in acute medically ill patients with bronchiectasis","volume":"27","author":"Lipardi","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.opresp.2024.100392_bib1500","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pulmoe.2018.09.006","article-title":"COPD and cardiovascular disease","volume":"25","author":"Andr\u00e9","year":"2019","journal-title":"Pulmonology"},{"key":"10.1016\/j.opresp.2024.100392_bib1505","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1378\/chest.12-2847","article-title":"Cardiovascular comorbidity in COPD: systematic literature review","volume":"144","author":"M\u00fcllerova","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1510","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1164\/rccm.201604-0690SO","article-title":"Chronic obstructive pulmonary disease and cardiac diseases an urgent need for integrated care","volume":"194","author":"Roversi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1515","series-title":"ERS Monogr","first-page":"47","article-title":"Cardiovascular disease in copd","author":"Rogliani","year":"2020"},{"key":"10.1016\/j.opresp.2024.100392_bib1520","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.rmed.2013.05.001","article-title":"Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort","volume":"107","author":"Miller","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1525","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/thoraxjnl-2012-203151","article-title":"Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality","volume":"69","author":"Williams","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.opresp.2024.100392_bib1530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1378\/chest.09-2810","article-title":"Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation","volume":"138","author":"Watz","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1535","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1378\/chest.13-0183","article-title":"Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The multi-ethnic study of atherosclerosis COPD study","volume":"144","author":"Smith","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1540","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/CIRCULATIONAHA.113.001653","article-title":"Pulmonary hyperinflation and left ventricular mass: the multi-ethnic study of atherosclerosis COPD study","volume":"127","author":"Smith","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.opresp.2024.100392_bib1545","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa0808836","article-title":"Percent emphysema, airflow obstruction, and impaired left ventricular filling","volume":"362","author":"Barr","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1550","first-page":"199","article-title":"Hypoxemia in patients with COPD: cause, effects, and disease progression","volume":"6","author":"Kent","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.opresp.2024.100392_bib1555","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40749-015-0008-8","article-title":"Lung hyperinflation in COPD: applying physiology to clinical practice","volume":"1","author":"O\u2019Donnell","year":"2015","journal-title":"COPD Res Pract"},{"key":"10.1016\/j.opresp.2024.100392_bib1560","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","article-title":"Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease","volume":"203","author":"Halpin","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1565","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1570","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1183\/09031936.00087312","article-title":"The study to understand mortality and morbidity in COPD (SUMMIT) study protocol","volume":"41","author":"Vestbo","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib1575","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa1303342","article-title":"Tiotropium Respimat inhaler and the risk of death in COPD","volume":"369","author":"Wise","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1580","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1585","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2213-2600(18)30054-7","article-title":"Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial","volume":"6","author":"Hohlfeld","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1590","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/CRD.0000000000000284","article-title":"Beta adrenergic blocker use in patients with chronic obstructive pulmonary disease and concurrent chronic heart failure with a low ejection fraction","volume":"28","author":"Mtisi","year":"2020","journal-title":"Cardiol Rev"},{"issue":"Suppl.","key":"10.1016\/j.opresp.2024.100392_bib1595","doi-asserted-by":"crossref","first-page":"e455S","DOI":"10.1378\/chest.12-2366","article-title":"Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Simoff","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1600","first-page":"e20924","article-title":"Malignant superior vena cava syndrome: state of the art","volume":"14","author":"Patriarcheas","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.opresp.2024.100392_bib1605","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3892\/etm.2022.11679","article-title":"Prevalence and treatment of venous thromboembolism in patients with solid tumors","volume":"24","author":"Zhao","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1610","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3400\/avd.cr.21-00102","article-title":"Acute limb ischemia caused by embolus of primary lung cancer complicating Trousseau's syndrome","volume":"15","author":"Tanaka","year":"2022","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.opresp.2024.100392_bib1615","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/heartviews.heartviews_21_22","article-title":"Myocardial invasion of squamous cell lung carcinoma presenting as STEMI","volume":"23","author":"Anjum","year":"2022","journal-title":"Heart Views"},{"key":"10.1016\/j.opresp.2024.100392_bib1620","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hfc.2022.02.007","article-title":"Cardiovascular imaging in cardio-oncology: the role of echocardiography and cardiac MRI in modern cardio-oncology","volume":"18","author":"Gambril","year":"2022","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.opresp.2024.100392_bib1625","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5858\/arpa.2021-0418-OA","article-title":"Cardiac metastasis from solid cancers: a 35-year single-center autopsy study","volume":"147","author":"Nova-Camacho","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1630","first-page":"82","article-title":"Cardiac and lymphatic metastases from lung cancer","volume":"21","author":"Dos Santos","year":"2018","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1635","first-page":"e1711","article-title":"Cardiac metastasis from small cell lung cancer origin: a case report and review of the literature","volume":"5","author":"Tian","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.opresp.2024.100392_bib1640","first-page":"e6090","article-title":"Non-sustained ventricular tachycardia as a sign of lung cancer","volume":"11","author":"Haq","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.opresp.2024.100392_bib1645","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/0366-6999.223842","article-title":"Sustained ventricular tachycardia secondary to cardiac metastasis of lung cancer","volume":"131","author":"Li","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.opresp.2024.100392_bib1650","first-page":"173","article-title":"Cardiac metastasis of lung cancer presented as mimicking ST-elevation myocardial infarction with reciprocal electrocardiographic changes","volume":"26","author":"Kunishige","year":"2022","journal-title":"J Cardiol Cases"},{"key":"10.1016\/j.opresp.2024.100392_bib1655","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12433","article-title":"The relationship between J waves and contact of lung cancer with the heart","volume":"22","author":"Hayashi","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1660","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13256-021-03244-z","article-title":"Complete heart block ensuing from a metastatic small cell carcinoma: a case report","volume":"16","author":"Pallangyo","year":"2022","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1665","series-title":"S\u00edndromes paraneopl\u00e1sicos en el c\u00e1ncer de pulm\u00f3n. Manual de la Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Cap\u00edtulo 67","author":"Rodriguez Hermosa","year":"2018"},{"key":"10.1016\/j.opresp.2024.100392_bib1670","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009974","article-title":"Cardio-respiratory failure secondary to ectopic Cushing's syndrome as the index presentation of small-cell lung cancer","volume":"2013","author":"von Stempel","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1675","first-page":"e1731","article-title":"Ectopic adrenocorticotropic hormone-secreting carcinoid with solitary cryptococcosis in the lungs","volume":"5","author":"Takagi","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"issue":"Suppl.","key":"10.1016\/j.opresp.2024.100392_bib1680","doi-asserted-by":"crossref","first-page":"e121S","DOI":"10.1378\/chest.12-2352","article-title":"Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Ost","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1685","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mus.21528","article-title":"Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer","volume":"41","author":"Peltier","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.opresp.2024.100392_bib1690","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1752-1947-7-112","article-title":"Paraneoplastic necrotizing myopathy associated with adenocarcinoma of the lung \u2013 a rare entity with atypical onset: a case report","volume":"7","author":"Acciavatti","year":"2013","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1695","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/jcecho.jcecho_68_21","article-title":"Nonbacterial thrombotic endocarditis with multiple systemic emboli in a patient with primary lung cancer","volume":"32","author":"Benedetti","year":"2022","journal-title":"J Cardiovasc Echogr"},{"issue":"Suppl. 1","key":"10.1016\/j.opresp.2024.100392_bib1700","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.thromres.2021.11.024","article-title":"Cancer-associated non-bacterial thrombotic endocarditis","volume":"213","author":"Itzhaki Ben Zadok","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.opresp.2024.100392_bib1705","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1710","unstructured":"Manual de estadificaci\u00f3n en Oncolog\u00eda Tor\u00e1cica. Asociaci\u00f3n Internacional para el Estudio del C\u00e1ncer de Pulm\u00f3n (IASLC). Parte II. Cap\u00edtulo 5. Notas aclaratorias para localizaciones espec\u00edficas en el c\u00e1ncer de pulm\u00f3n. Traducci\u00f3n espa\u00f1ola. Rami-Porta R editor. Editorial Respira. 2016. Available from: https:\/\/issuu.com\/separ\/docs\/manual_estadificaci_n_ct__2019__-we?e=3049452\/67764561 [accessed 27.2.23]."},{"key":"10.1016\/j.opresp.2024.100392_bib1715","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jtho.2023.12.006","article-title":"The international association for the study of lung cancer lung cancer staging project: proposals for the revisions of the T-descriptors in the forthcoming ninth edition of the TNM classification for lung cancer","volume":"19","author":"Van Schil","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1720","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jtho.2024.01.019","article-title":"The international association for the study of lung cancer staging project for lung cancer: proposals for the revision of the M descriptors in the forthcoming 9th edition of the TNM classification of lung cancer","volume":"19","author":"Fong","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1725","doi-asserted-by":"crossref","unstructured":"British Thoracic Society Bronchoscopy Guidelines Committee, a Subcommittee of Standards of Care Committee of British Thoracic Society. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax. 2001; Suppl. 1: i1\u201321.","DOI":"10.1136\/thx.56.suppl_1.i1"},{"key":"10.1016\/j.opresp.2024.100392_bib1730","series-title":"Broncoscopia diagn\u00f3stica. Manual de la Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Cap\u00edtulo 11","author":"Revuelta Salgado","year":"2018"},{"key":"10.1016\/j.opresp.2024.100392_bib1735","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1183\/09031936.97.10030695","article-title":"Cardiovascular consequences of fibreoptic bronchoscopy","volume":"10","author":"Davies","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib1740","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1378\/chest.112.6.1454","article-title":"Myocardial ischemia in sedated patients undergoing fiberoptic bronchoscopy","volume":"112","author":"Matot","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1745","unstructured":"Vidal Garc\u00eda I, M\u00e9ndez Salazar FA, Elguezabal Bilbao E. In: Flandes Aldeyturriaga J, Montero Mart\u00ednez C, Andreo Garc\u00eda F, eds. Monitorizaci\u00f3n del paciente durante el procedimiento. Seguridad en endoscopia respiratoria. Manual Separ de procedimientos. Cap\u00edtulo 3.2. 2020. Available from: https:\/\/issuu.com\/separ\/docs\/manual_procedimientos_separ__seguridad_en_endoscop?fr=sOTliMjE2NjczNg [accessed 17.2.23]."},{"key":"10.1016\/j.opresp.2024.100392_bib1750","unstructured":"Montero Mart\u00ednez C, Fern\u00e1ndez Marrube M, Pereiro Brea T, Villar Aguilar L. In: Flandes Aldeyturriaga J, Montero Mart\u00ednez C, Andreo Garc\u00eda F, eds. Seguridad para el paciente. Seguridad en endoscopia respiratoria. Manual Separ de procedimientos. Cap\u00edtulo 3.1. 2020. Available from: https:\/\/issuu.com\/separ\/docs\/manual_procedimientos_separ__seguridad_en_endoscop?fr=sOTliMjE2NjczNg [accessed 18.2.23]."},{"issue":"Suppl.","key":"10.1016\/j.opresp.2024.100392_bib1755","doi-asserted-by":"crossref","first-page":"e166S","DOI":"10.1378\/chest.12-2395","article-title":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Brunelli","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1760","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2015.01.006","article-title":"Cardiovascular comorbidities and survival of lung cancer patients: medicare data based analysis","volume":"88","author":"Kravchenko","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.opresp.2024.100392_bib1765","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/1055-9965.EPI-15-0036","article-title":"Comorbidity and survival in lung cancer patients","volume":"24","author":"Islam","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.opresp.2024.100392_bib1770","doi-asserted-by":"crossref","first-page":"984951","DOI":"10.3389\/fcvm.2022.984951","article-title":"Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?","volume":"9","author":"M\u0119drek","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1775","first-page":"e30643","article-title":"Risk stratification for lung cancer patients","volume":"14","author":"Jain","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.opresp.2024.100392_bib1780","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ejcts\/ezv154","article-title":"Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database","volume":"49","author":"Falcoz","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.opresp.2024.100392_bib1785","doi-asserted-by":"crossref","first-page":"E656","DOI":"10.59958\/hsf.5877","article-title":"A review of advances in the surgical treatment of coronary heart disease and lung cancer","volume":"26","author":"Hong","year":"2023","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.opresp.2024.100392_bib1790","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.hlc.2017.06.729","article-title":"Is the risk of postoperative atrial fibrillation predictable in patients undergoing surgery due to primary lung cancer?","volume":"27","author":"Kavurmaci","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.opresp.2024.100392_bib1795","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00228-022-03383-2","article-title":"Pharmacological interventions for preventing atrial fibrillation after lung surgery: systematic review and meta-analysis","volume":"78","author":"Wang","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.opresp.2024.100392_bib1800","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13019-021-01607-7","article-title":"Perioperative outcomes of combined heart surgery and lung tumor resection: a systematic review and meta-analysis","volume":"16","author":"Cheng","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.opresp.2024.100392_bib1805","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ejcts\/ezaa360","article-title":"Staged management of cardiac disease and concomitant early lung cancer: a 20-year single-center experience","volume":"59","author":"Tricard","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.opresp.2024.100392_bib1810","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00595-021-02446-8","article-title":"Atrial resection for T4 non-small cell lung cancer with left atrium involvement: a systematic review and meta-analysis of survival","volume":"53","author":"Hamouri","year":"2023","journal-title":"Surg Today"},{"issue":"Suppl.","key":"10.1016\/j.opresp.2024.100392_bib1815","doi-asserted-by":"crossref","first-page":"e369S","DOI":"10.1378\/chest.12-2362","article-title":"Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Kozower","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib1820","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11748-017-0752-6","article-title":"Extended surgery for T4 lung cancer: a 30 years\u2019 experience","volume":"65","author":"Dartevelle","year":"2017","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.opresp.2024.100392_bib1825","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.3390\/cancers14246138","article-title":"Multicenter retrospective cohort study on superior vena cava resection in non-small-cell lung cancer surgery","volume":"14","author":"Dell\u2019Amore","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.opresp.2024.100392_bib1830","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.athoracsur.2015.01.059","article-title":"Safe resection of the aortic wall infiltrated by lung cancer after placement of an endoluminal prosthesis","volume":"99","author":"Marulli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.opresp.2024.100392_bib1835","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/jcm11010146","article-title":"Radiation-induced heart disease","volume":"11","author":"Quintero-Martinez","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1840","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaccao.2023.08.007","article-title":"Predicting adverse cardiac events after radiotherapy for locally advanced non-small cell lung cancer","volume":"5","author":"No","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1845","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14779072.2018.1538785","article-title":"Radiation and the heart: systematic review of dosimetry and cardiac endpoints","volume":"16","author":"Niska","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.opresp.2024.100392_bib1850","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cllc.2019.05.014","article-title":"Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer","volume":"20","author":"Borkenhagen","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.opresp.2024.100392_bib1855","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer","volume":"73","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib1860","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11912-023-01387-4","article-title":"Cardiovascular toxicity and risk mitigation with lung cancer treatment","volume":"25","author":"Yegya-Raman","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1865","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1016\/j.clon.2022.11.019","article-title":"Cardiac morbidity following chemoradiation in stage III non-small cell lung cancer patients: a population-based cohort study","volume":"35","author":"Donovan","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.opresp.2024.100392_bib1870","doi-asserted-by":"crossref","first-page":"1068957","DOI":"10.3389\/fcvm.2022.1068957","article-title":"Association between radiotherapy and risk of death from cardiovascular diseases in lung and bronchus cancer","volume":"9","author":"Yi","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1875","article-title":"Cardiac adverse events associated with chemo-radiation versus chemotherapy for resectable stage III non-small-cell lung cancer: a surveillance","volume":"11","author":"Herbach","year":"2022","journal-title":"Epidemiology and End Results-Medicare Study. J Am Heart Assoc"},{"key":"10.1016\/j.opresp.2024.100392_bib1880","doi-asserted-by":"crossref","first-page":"e21964","DOI":"10.1097\/MD.0000000000021964","article-title":"Heart dose linked with cardiac events and overall survival in lung cancer radiotherapy: a meta-analysis","volume":"99","author":"Pan","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.opresp.2024.100392_bib1885","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clon.2023.11.029","article-title":"The association of incidental radiation dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for non-small cell lung cancer: results from the NI-HEART study","volume":"36","author":"Walls","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.opresp.2024.100392_bib1890","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/cco-23-125","article-title":"The effects of radiation therapy on the heart: implications for management","volume":"13","author":"Hsieh","year":"2024","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1895","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.2147\/CMAR.S200837","article-title":"Association of lung and heart dose with survival in patients with non-small cell lung cancer underwent volumetric modulated arc therapy","volume":"11","author":"Shen","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.opresp.2024.100392_bib1900","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s11864-022-01012-9","article-title":"Radiation-induced cardiovascular toxicities","volume":"23","author":"Badiyan","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1905","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib1910","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12032-017-1012-4","article-title":"Lung cancer as a cardiotoxic state: a review","volume":"34","author":"P\u00e9rez-Callejo","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1915","doi-asserted-by":"crossref","first-page":"1340373","DOI":"10.3389\/fimmu.2024.1340373","article-title":"Immune checkpoint inhibitors associated cardiovascular immune-related adverse events","volume":"15","author":"Jo","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.opresp.2024.100392_bib1920","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.opresp.2024.100392_bib1925","first-page":"4751","article-title":"Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.opresp.2024.100392_bib1930","doi-asserted-by":"crossref","first-page":"908173","DOI":"10.3389\/fimmu.2022.908173","article-title":"Cardiovascular toxicity with PD-1\/PD-L1 inhibitors in cancer patients: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.opresp.2024.100392_bib1935","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1940","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14740338.2023.2182284","article-title":"Risks of cardiovascular toxicities associated with ALK tyrosine kinase inhibitors in patients with non-small-cell lung cancer: a meta-analysis of randomized control trials","volume":"22","author":"Zhao","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.opresp.2024.100392_bib1945","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1950","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11886-023-01845-2","article-title":"Cardiovascular toxicities associated with tyrosine kinase inhibitors","volume":"25","author":"Sayegh","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.opresp.2024.100392_bib1955","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune check point inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.opresp.2024.100392_bib1960","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.3390\/cancers14215403","article-title":"Cardiotoxicity induced by immune checkpoint inhibitors: what a cardio-oncology team should know and do","volume":"14","author":"Zito","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.opresp.2024.100392_bib1965","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002435","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events","volume":"9","author":"Brahmer","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.opresp.2024.100392_bib1970","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1002\/cam4.1754","article-title":"Incidence of cardiovascular disease up to 13 year after cancer diagnosis: a matched cohort study among 32,757 cancer survivors","volume":"7","author":"Schoormans","year":"2018","journal-title":"Cancer Med"},{"issue":"Suppl. M","key":"10.1016\/j.opresp.2024.100392_bib1975","doi-asserted-by":"crossref","first-page":"M44","DOI":"10.1093\/eurheartj\/suz230","article-title":"Monitoring the heart during cancer therapy","volume":"21","author":"Habibian","year":"2019","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.opresp.2024.100392_bib1980","doi-asserted-by":"crossref","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","article-title":"Management of immunotherapy-related toxicities, version 1. 2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Thompson","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.opresp.2024.100392_bib1985","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)","volume":"353","author":"Goldhaber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.opresp.2024.100392_bib1990","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S2213-2600(19)30360-1","article-title":"Pulmonary embolism in Europe remains a cause of concern despite declining deaths","volume":"8","author":"Bikdeli","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib1995","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/jcp.2003.013581","article-title":"Fatal pulmonary embolism in hospitalised patients: a necropsy review","volume":"57","author":"Alikhan","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.opresp.2024.100392_bib2000","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacc.2015.10.060","article-title":"Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry","volume":"67","author":"Jim\u00e9nez","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib2005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.chest.2019.05.021","article-title":"Age-stratified national trends in pulmonary embolism admissions","volume":"156","author":"Pauley","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib2010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1055\/s-0036-1598005","article-title":"Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review","volume":"43","author":"Bikdeli","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.opresp.2024.100392_bib2015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/acem.12769","article-title":"Findings from 12-lead electrocardiography that predict circulatory shock from pulmonary embolism: systematic review and meta-analysis","volume":"22","author":"Shopp","year":"2015","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.200907-1141OC","article-title":"Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events","volume":"181","author":"Klok","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2025","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants\u2019 data from seven trials","volume":"342","author":"Boutitie","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.opresp.2024.100392_bib2030","doi-asserted-by":"crossref","first-page":"l4363","DOI":"10.1136\/bmj.l4363","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.opresp.2024.100392_bib2035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: chest guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib2040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib2045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01915-2018","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"53","author":"Kim","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib2050","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jtcvs.2016.05.058","article-title":"Hemodynamic and ventilatory responses during exercise in chronic thromboembolic disease","volume":"152","author":"van Kan","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.opresp.2024.100392_bib2055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.arbr.2020.07.003","article-title":"Early and late cardiovascular events in patients hospitalized for community-acquired pneumonia","volume":"56","author":"Ald\u00e1s","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.opresp.2024.100392_bib2060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjcard.2015.05.028","article-title":"Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events","volume":"116","author":"Cangemi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib2065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ahj.2015.04.028","article-title":"Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults","volume":"170","author":"Corrales-Medina","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib2070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/resp.13233","article-title":"Pneumonia as a cardiovascular disease","volume":"23","author":"Restrepo","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.opresp.2024.100392_bib2075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2014.07.985","article-title":"Platelet activation is associated with myocardial infarction in patients with pneumonia","volume":"64","author":"Cangemi","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib2085","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.opresp.2024.100392_bib2090","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1160\/TH14-05-0455","article-title":"Neutrophil extracellular traps and the role of platelets in infection","volume":"112","author":"Andrews","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.opresp.2024.100392_bib2095","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/biomedicines10081850","article-title":"Neutrophils and neutrophil extracellular traps in cardiovascular disease: an overview and potential therapeutic approaches","volume":"10","author":"Shirakawa","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.opresp.2024.100392_bib2100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"D\u00f6ring","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.opresp.2024.100392_bib2105","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.febslet.2010.06.006","article-title":"Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death","volume":"584","author":"Gupta","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.opresp.2024.100392_bib2110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.chest.2019.06.040","article-title":"Community-acquired pneumonia patients at-risk for early and long-term cardiovascular events are identified by cardiac biomarkers","volume":"156","author":"Men\u00e9ndez","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib2115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059713","article-title":"Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study","volume":"12","author":"Nishimura","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.opresp.2024.100392_bib2120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/rccm.201701-0104OC","article-title":"Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling","volume":"196","author":"Reyes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004836","article-title":"Circulating pneumolysin is a potent inducer of cardiac injury during pneumococcal infection","volume":"11","author":"Alhamdi","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.opresp.2024.100392_bib2130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2007.086785","article-title":"Markers of treatment failure in hospitalised community acquired pneumonia","volume":"63","author":"Men\u00e9ndez","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.opresp.2024.100392_bib2135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.vaccine.2017.11.078","article-title":"Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases","volume":"36","author":"Ciszewski","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.opresp.2024.100392_bib2140","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01556-18","article-title":"A hypothesis-generating study of the combination of aspirin plus macrolides in patients with severe community-acquired pneumonia","volume":"63","author":"Falcone","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.opresp.2024.100392_bib2145","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1164\/rccm.201812-2328OC","article-title":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia: a pilot randomised controlled trial","volume":"200","author":"Sapey","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1513\/AnnalsATS.201806-419OC","article-title":"Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia","volume":"16","author":"Cangemi","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.opresp.2024.100392_bib2155","doi-asserted-by":"crossref","unstructured":"American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161(Pt 1): 646\u201364.","DOI":"10.1164\/ajrccm.161.2.ats3-00"},{"key":"10.1016\/j.opresp.2024.100392_bib2160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.arbres.2013.03.011","article-title":"Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR) Research Group on Diffuse Pulmonary Diseases","volume":"49","author":"Xaubet","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2024.100392_bib2165","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151425","article-title":"Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis","volume":"11","author":"Kreuter","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.opresp.2024.100392_bib2175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.rmed.2014.01.008","article-title":"How does comorbidity influence survival in idiopathic pulmonary fibrosis?","volume":"108","author":"Hyldgaard","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12931-019-1020-3","article-title":"The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry","volume":"20","author":"Kreuter","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.opresp.2024.100392_bib2185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000495046","article-title":"Nintedanib in idiopathic pulmonary fibrosis: practical management recommendations for potential adverse events","volume":"97","author":"Bendstrup","year":"2019","journal-title":"Respiration"},{"key":"10.1016\/j.opresp.2024.100392_bib2190","first-page":"309","article-title":"Managing comorbidities in idiopathic pulmonary fibrosis","volume":"8","author":"Fulton","year":"2015","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2195","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCP.0000000000000790","article-title":"Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment","volume":"27","author":"Behr","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2200","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000524263","article-title":"The effect of borderline pulmonary hypertension on survival in chronic lung disease","volume":"101","author":"Piccari","year":"2022","journal-title":"Respiration"},{"key":"10.1016\/j.opresp.2024.100392_bib2205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostenil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2210","doi-asserted-by":"crossref","first-page":"e12127","DOI":"10.1002\/pul2.12127","article-title":"Clinical significance of pulmonary hypertension in interstitial lung disease: a consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension","volume":"12","author":"Nikkho","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.opresp.2024.100392_bib2215","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society Clinical Practice Guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1465-9921-6-95","article-title":"Incidence of asthma and mortality in a cohort of young adults: a 7-year prospective study","volume":"6","author":"De Marco","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.opresp.2024.100392_bib2225","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.rmed.2007.03.006","article-title":"Factors associated with mortality after an asthma admission: a national United Kingdom database analysis","volume":"101","author":"Watson","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2466-13-73","article-title":"Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study","volume":"13","author":"Soto-Campos","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2235","doi-asserted-by":"crossref","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in Primary Care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2024.100392_bib2240","first-page":"46","article-title":"The comorbidity burden of treated asthma patient population in British Columbia","volume":"30","author":"Prosser","year":"2010","journal-title":"Chronic Dis Can"},{"key":"10.1016\/j.opresp.2024.100392_bib2245","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.rmed.2012.02.017","article-title":"Association of adult-onset asthma with specific cardiovascular conditions","volume":"106","author":"Lee","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2250","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1164\/rccm.201502-0302OC","article-title":"Characteristics and prognosis of never-smokers and smokers with asthma in the Copenhagen General Population Study. A prospective cohort study","volume":"192","author":"\u00c7olak","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2255","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/aje\/kws181","article-title":"Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts","volume":"176","author":"Iribarren","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.opresp.2024.100392_bib2260","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.amjcard.2007.12.024","article-title":"Relation of adult-onset asthma to coronary heart disease and stroke","volume":"101","author":"Onufrak","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib2265","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/thx.2004.026484","article-title":"Asthma and incident cardiovascular disease: the atherosclerosis risk in communities study","volume":"60","author":"Schanen","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.opresp.2024.100392_bib2270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003448","article-title":"Late-onset asthma predicts cardiovascular disease events: the Wisconsin sleep cohort","volume":"5","author":"Tattersall","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.opresp.2024.100392_bib2275","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/ATVBAHA.115.305452","article-title":"Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis","volume":"35","author":"Tattersall","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.opresp.2024.100392_bib2280","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.anai.2017.03.012","article-title":"Asthma and risk of coronary heart disease: a meta-analysis of cohort studies","volume":"118","author":"Liu","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.opresp.2024.100392_bib2285","article-title":"Association of asthma with coronary heart disease: a meta analysis of 11 trials","volume":"12","author":"Wang","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.opresp.2024.100392_bib2290","doi-asserted-by":"crossref","first-page":"861798","DOI":"10.3389\/fcvm.2022.861798","article-title":"Association between asthma and all-cause mortality and cardiovascular disease morbidity and mortality: a meta-analysis of cohort studies","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2295","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaip.2016.02.018","article-title":"Asthma status and risk of incident myocardial infarction: a population-based case-control study","volume":"4","author":"Bang","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.opresp.2024.100392_bib2300","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaip.2019.06.043","article-title":"Risk of acute myocardial infarction and ischemic stroke in patients with asthma exacerbation: a population-based, self-controlled case series study","volume":"8","author":"Raita","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.opresp.2024.100392_bib2305","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fphar.2020.00166","article-title":"Cytokines at the interplay between asthma and atherosclerosis?","volume":"11","author":"Gurgone","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.opresp.2024.100392_bib2310","first-page":"1612","article-title":"An association between Prinzmetal's angina pectoris and obstructive lung disease","volume":"96","author":"Rich","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib2315","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00428-012-1351-7","article-title":"Eosinophlic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and review of the literature","volume":"462","author":"Kajihara","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.opresp.2024.100392_bib2320","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jcp.2009.074450","article-title":"Isolated eosinophlic coronary arteritis","volume":"63","author":"Arena","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.opresp.2024.100392_bib2325","doi-asserted-by":"crossref","first-page":"979","DOI":"10.5858\/arpa.2012-0610-RS","article-title":"Eosinophilic coronary monoarteritis","volume":"138","author":"Carreon","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2330","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0002-9149(99)00846-2","article-title":"Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris","volume":"85","author":"Umemoto","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.opresp.2024.100392_bib2335","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2010.02.038","article-title":"Eosinophilic cationic protein: a new biomarker of coronary atherosclerosis","volume":"211","author":"Niccoli","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.opresp.2024.100392_bib2340","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9343(03)00393-0","article-title":"Inhaled corticosteroid use in asthma and the prevention of myocardial infarction","volume":"115","author":"Suissa","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2345","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1183\/09031936.00150312","article-title":"Risk of deep vein thrombosis and pulmonary embolism in asthma","volume":"42","author":"Majoor","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib2350","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.166.9.1016","article-title":"Corticosteroids and the risk of atrial fibrillation","volume":"166","author":"van der Hooft","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2355","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rmed.2019.04.001","article-title":"Bronchodilators in subjects with asthma-related comorbidities","volume":"151","author":"Cazzola","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.opresp.2024.100392_bib2360","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.opresp.2024.100392_bib2365","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.healun.2022.08.007","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease","volume":"41","author":"Perch","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.opresp.2024.100392_bib2370","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.healun.2011.11.020","article-title":"Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease","volume":"31","author":"Andersen","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.opresp.2024.100392_bib2375","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00171307","article-title":"Pulmonary hypertension in interstitial lung disease","volume":"31","author":"Behr","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib2380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"Cottin","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib2385","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.healun.2010.04.006","article-title":"Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival","volume":"29","author":"Tonelli","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.opresp.2024.100392_bib2390","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcf.2013.12.004","article-title":"Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry","volume":"13","author":"Hayes","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.opresp.2024.100392_bib2395","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.athoracsur.2015.06.024","article-title":"Influence of pulmonary hypertension on patients with Idiopathic pulmonary fibrosis awaiting lung transplantation","volume":"101","author":"Hayes","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.opresp.2024.100392_bib2400","first-page":"817","article-title":"Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation","volume":"53","author":"Venuta","year":"2012","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.opresp.2024.100392_bib2405","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2024.100392_bib2410","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib2415","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib2420","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"issue":"Suppl. 2","key":"10.1016\/j.opresp.2024.100392_bib2425","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.opresp.2024.100392_bib2430","unstructured":"Available from: http:\/\/www.tools.acc.org\/ASCVD-Risk-Estimator\/."},{"key":"10.1016\/j.opresp.2024.100392_bib2435","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.100.10.1043","article-title":"Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery","volume":"100","author":"Lee","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.opresp.2024.100392_bib2440","unstructured":"Available from: http:\/\/www.samiuc.es\/revised-cardiac-risk-index-lee\/."},{"key":"10.1016\/j.opresp.2024.100392_bib2445","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.110.015701","article-title":"Development and validation of a risk calculator for prediction of cardiac risk after surgery","volume":"124","author":"Gupta","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.opresp.2024.100392_bib2450","unstructured":"Available from: http:\/\/www.surgicalriskcalculator.com\/miorcardiacarrest."},{"key":"10.1016\/j.opresp.2024.100392_bib2455","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.mcna.2017.03.002","article-title":"Cardiovascular risk assessment","volume":"101","author":"Pletcher","year":"2017","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.opresp.2024.100392_bib2460","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.opresp.2024.100392_bib2465","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib2470","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thorsurg.2022.01.004","article-title":"Nonallograft complications of lung transplantation","volume":"32","author":"Thaniyavarn","year":"2022","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.opresp.2024.100392_bib2475","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.ajkd.2021.10.014","article-title":"CKD in recipients of nonkidney solid organ transplants: a review","volume":"80","author":"Wiseman","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.opresp.2024.100392_bib2480","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.opresp.2024.100392_bib2485","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/tri.13783","article-title":"Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics","volume":"34","author":"Hecking","year":"2021","journal-title":"Transpl Int"}],"container-title":["Open Respiratory Archives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663624001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663624001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T17:33:09Z","timestamp":1753205589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2659663624001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":298,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2659663624001140"],"URL":"https:\/\/doi.org\/10.1016\/j.opresp.2024.100392","relation":{},"ISSN":["2659-6636"],"issn-type":[{"value":"2659-6636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory Pathology and Cardiovascular Diseases: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Open Respiratory Archives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.opresp.2024.100392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100392"}}